Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Hearing01:31

Hearing

56.8K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
56.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K
Line Loss01:10

Line Loss

518
The different configurations of source-load connections include wye (star) and delta connections. The relationship between line and phase voltages and currents varies depending on the configuration. When the source is supplying power, it is transmitted through the wires to the load, and during this transmission, some power is absorbed by the wires, leading to line loss.
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
518
Reducing Line Loss01:18

Reducing Line Loss

371
In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
371
Major Losses in Pipes01:28

Major Losses in Pipes

1.9K
When a fluid flows through a pipe, it experiences energy losses due to frictional resistance along the pipe walls, known as major losses. These energy losses result in a pressure drop, which varies based on the flow conditions — whether laminar or turbulent — and the specific physical properties of the fluid and pipe.
Fluid flow can be classified as laminar or turbulent, primarily based on the Reynolds number. This dimensionless number reflects the relative influence of inertial to viscous...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A personalized genomic medicine approach to rare genomic disorders associated with simple chromosomal structural variants.

HGG advances·2026
Same author

The <i>TECTB-C225Y</i> Variant Causing Autosomal Dominant Deafness in a Nicaraguan Family Enhances Sensitivity to Noise-Induced Hearing Loss in Mice.

medRxiv : the preprint server for health sciences·2025
Same author

2024 ASHG Leadership Award.

American journal of human genetics·2025
Same author

Newborn Screening for Deafness/Hard of Hearing in the Genomic Era.

Clinical chemistry·2025
Same author

Resolution of ring chromosomes, Robertsonian translocations, and complex structural variants from long-read sequencing and telomere-to-telomere assembly.

American journal of human genetics·2024
Same author

Chromosomal structural rearrangements implicate long non-coding RNAs in rare germline disorders.

Human genetics·2024

Related Experiment Video

Updated: Jan 23, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.8K

Gene therapy for hearing loss.

Ryotaro Omichi1,2, Seiji B Shibata1,3, Cynthia C Morton4,5,6

  • 1Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Human Molecular Genetics
|June 23, 2019
PubMed
Summary
This summary is machine-generated.

Gene therapy offers new hope for sensorineural hearing loss (SNHL), the most common sensory disorder. Research explores molecular treatments like gene replacement and editing to restore hearing, moving towards clinical trials.

More Related Videos

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
03:49

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation

Published on: October 11, 2024

1.2K
Modified Experimental Conditions for Noise-Induced Hearing Loss in Mice and Assessment of Hearing Function and Outer Hair Cell Damage
07:13

Modified Experimental Conditions for Noise-Induced Hearing Loss in Mice and Assessment of Hearing Function and Outer Hair Cell Damage

Published on: February 10, 2023

2.8K

Related Experiment Videos

Last Updated: Jan 23, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.8K
Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
03:49

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation

Published on: October 11, 2024

1.2K
Modified Experimental Conditions for Noise-Induced Hearing Loss in Mice and Assessment of Hearing Function and Outer Hair Cell Damage
07:13

Modified Experimental Conditions for Noise-Induced Hearing Loss in Mice and Assessment of Hearing Function and Outer Hair Cell Damage

Published on: February 10, 2023

2.8K

Area of Science:

  • Otolaryngology
  • Genetics
  • Molecular Biology

Background:

  • Sensorineural hearing loss (SNHL) is a prevalent sensory disorder with diverse genetic and environmental causes.
  • Current management relies on amplification devices, but novel therapeutic strategies are emerging.
  • Gene therapy presents a promising avenue for restoring and preventing SNHL.

Purpose of the Study:

  • To review molecular therapies for SNHL, including gene replacement, antisense oligonucleotides, RNA interference, and CRISPR-based gene editing.
  • To discuss delivery methods, techniques, and viral vectors for inner ear gene therapy.
  • To highlight advancements enabling the transition of basic science discoveries to clinical applications.

Main Methods:

  • Literature review of molecular therapies for SNHL.
  • Analysis of gene therapy delivery systems for the inner ear.
  • Discussion of gene editing technologies like CRISPR.

Main Results:

  • Proof-of-principle studies show potential for molecular agents to ameliorate SNHL.
  • Gene replacement and editing are key strategies for treating genetic hearing loss.
  • Various delivery methods and viral vectors are being investigated for inner ear gene therapy.

Conclusions:

  • Molecular therapies, particularly gene-based strategies, hold significant potential for treating SNHL.
  • Advancements in gene therapy are paving the way for clinical trials.
  • Restoring or preventing genetic hearing loss through molecular interventions is becoming a tangible reality.